Isabel Jaco
Company: Novartis AG
Job title: Senior Principal Scientist
Seminars:
Panel Discussion: Balancing Novel Biomarkers for Multiple Cancer Types for DDR Inhibitor Development 12:00 pm
• Can we repurpose biomarkers used by other areas of oncology? • What do we need to know to develop and validate biomarkers amongst the complexity of DDR pathways? • Are novel target specific biomarkers for every novel target a worthwhile pursuit or realistic goal? Should we aim for a universal DDR biomarker?Read more
day: Pre-Conference Day
Chair’s Opening Remarks 9:20 am
day: Pre-Conference Day